Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5
about
Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancerComparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAKHomology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5).In silico identification of potential key regulatory factors in smoking-induced lung cancer.Up-regulated microRNA499a by hepatitis B virus induced hepatocellular carcinogenesis via targeting MAPK6Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions.Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.Cross-talk between the circadian clock and the cell cycle in cancer.The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cellsMAPK6/MAPK4 signalingL290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.p-S MAPK6 phosphorylates NCOA3p-S857 NCOA3:ETV4 bind MMP2 and MMP10 promoterp-S MAPK6;4:p-T182 MAPKAPK5 translocate to the cytosolp-S MAPKAPK5 phosphorylates HSPB1p-T182 MAPKAPK5 phosphorylates FOXO3p-S215 FOXO3 translocates to the nucleusMYC mRNA translation is negatively regulated by miR-34B and CMYC positively regulates MAPKAPK5 gene expressionIGF2BP1 binds MAPK4 mRNAIGF2BP1 represses translation of MAPK4 mRNAThe atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture.
P2860
Q27021391-E45F66B0-77D1-4471-969E-2B1F33EE6E5BQ28547394-48987F5D-A027-47E3-85A5-3253D82F1F65Q30558424-68D43C74-D5DF-4B5D-90EC-AD9CC0B33DCBQ33776567-AE6E1C26-076D-4DCF-BFEE-F706A4E84C85Q34395799-05C67EF6-7A80-4176-B2FF-B5DA5E39C760Q37203214-20C3E1EB-9E6A-473C-B9B4-BA8E63B36DCEQ37671148-8E71EA4C-68C0-4297-B072-2D030B8F376FQ38208057-F9AF2769-59F5-49B3-AD4B-BE68B64B7CD1Q41887469-B95239C0-B4CD-4AFF-A8FF-41D2BA783C7AQ42244159-12F2E433-9CA4-4D58-AE96-BBE53300F116Q45318290-C2FDF692-5BC0-42E8-A3DA-114762774901Q46863041-D3146C08-6702-4E24-BA67-1CCFD74701D8Q50299035-F476AE78-C2E5-4E5B-AAEA-8786DA06E410Q50299038-63E02ED5-0B3B-4FF5-85CA-3DD80FDD25C8Q50299041-08337FE3-E9C0-4A1D-91C4-5C6A19A38730Q50299047-4689370F-F421-417B-8433-BB803DAD8C3DQ50299051-04A89F3F-E0CC-494E-B3A8-D594CDA6006FQ50299054-21C65292-E3C3-46D3-8671-273F9387D716Q50299058-B055771B-6E9C-4812-975E-1A1EFA326D8AQ50299060-2CBA98B6-CFE6-42D2-87E1-DF0DAF3ABA12Q50299061-DD3FE771-1EFB-48D1-8288-003A9B144E81Q50299063-CEC52DA6-B4BE-4223-90EF-0853B6189267Q54115214-06E38D40-F8D1-423C-B36D-74838BB3E825
P2860
Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumour promoting and suppressi ...... signalling pathway ERK3/4-MK5
@en
type
label
Tumour promoting and suppressi ...... signalling pathway ERK3/4-MK5
@en
prefLabel
Tumour promoting and suppressi ...... signalling pathway ERK3/4-MK5
@en
P2093
P2860
P356
P1476
Tumour promoting and suppressi ...... signalling pathway ERK3/4-MK5
@en
P2093
Gianina Dumitriu
Sergiy Kostenko
P2860
P356
10.1186/1750-2187-7-9
P577
2012-07-16T00:00:00Z